Atlas Trials

Assessment of Efficacy and Safety of Topical Administration of 1% Glycopyrronium Bromide (GPB) in Patients With Primary Axillary Hyperhidrosis and the Assessment of Long-term Efficacy and Safety of Topical Administration of 1% GPB Cream in Patients With Primary Axillary Hyperhidrosis.

Clinical trial NCT03658616 · COMPLETED

Trial details

NCT number
NCT03658616
Sponsor
Dr. August Wolff GmbH & Co. KG Arzneimittel
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Primary Axillary Hyperhidrosis
Start date
2018-09-18
Primary completion
2021-11-02
Enrollment
518

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.